CA3167902A1 - Prediction method for indication of aimed drug or equivalent substance of drug, prediction apparatus, and prediction program - Google Patents

Prediction method for indication of aimed drug or equivalent substance of drug, prediction apparatus, and prediction program

Info

Publication number
CA3167902A1
CA3167902A1 CA3167902A CA3167902A CA3167902A1 CA 3167902 A1 CA3167902 A1 CA 3167902A1 CA 3167902 A CA3167902 A CA 3167902A CA 3167902 A CA3167902 A CA 3167902A CA 3167902 A1 CA3167902 A1 CA 3167902A1
Authority
CA
Canada
Prior art keywords
drug
prediction
indication
data
artificial intelligence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3167902A
Other languages
English (en)
French (fr)
Inventor
Narutoku SATO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karydo TherapeutiX Inc
Original Assignee
Karydo TherapeutiX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karydo TherapeutiX Inc filed Critical Karydo TherapeutiX Inc
Publication of CA3167902A1 publication Critical patent/CA3167902A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/004—Artificial life, i.e. computing arrangements simulating life
    • G06N3/008—Artificial life, i.e. computing arrangements simulating life based on physical entities controlled by simulated intelligence so as to replicate intelligent life forms, e.g. based on robots replicating pets or humans in their appearance or behaviour
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Software Systems (AREA)
  • Computing Systems (AREA)
  • Artificial Intelligence (AREA)
  • Mathematical Physics (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
CA3167902A 2020-01-17 2021-01-15 Prediction method for indication of aimed drug or equivalent substance of drug, prediction apparatus, and prediction program Pending CA3167902A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-006304 2020-01-17
JP2020006304 2020-01-17
PCT/JP2021/001265 WO2021145434A1 (ja) 2020-01-17 2021-01-15 目的とする薬剤又はその等価物質の適応症の予測方法、予測装置、及び予測プログラム

Publications (1)

Publication Number Publication Date
CA3167902A1 true CA3167902A1 (en) 2021-07-22

Family

ID=76863781

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3167902A Pending CA3167902A1 (en) 2020-01-17 2021-01-15 Prediction method for indication of aimed drug or equivalent substance of drug, prediction apparatus, and prediction program

Country Status (6)

Country Link
US (1) US20230066502A1 (https=)
JP (1) JPWO2021145434A1 (https=)
CN (1) CN115315754A (https=)
CA (1) CA3167902A1 (https=)
IL (1) IL294698A (https=)
WO (1) WO2021145434A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6559850B1 (ja) 2018-07-27 2019-08-14 Ｋａｒｙｄｏ ＴｈｅｒａｐｅｕｔｉＸ株式会社 ヒトにおける被験物質の作用を予測するための人工知能モデル
EP4047607A4 (en) * 2019-10-17 2022-12-07 Karydo Therapeutix, Inc. ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTING INDICATIONS FOR TEST SUBSTANCES IN HUMANS
CN115486819B (zh) * 2022-11-15 2023-03-24 安徽星辰智跃科技有限责任公司 一种感知觉神经通路多级联检测量化的方法、系统和装置
EP4670187A1 (en) * 2023-02-21 2025-12-31 Genentech Inc. DEEP LEARNING-ACTIVATED PREDICTION OF DRUG-INDUCED LIVER INJURY
JPWO2024202431A1 (https=) 2023-03-31 2024-10-03

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6338538A (ja) 1986-07-31 1988-02-19 Sumitomo Metal Mining Co Ltd ニツケル硫化物からのニツケルの回収方法
AU2001278075A1 (en) * 2000-07-28 2002-02-13 Lion Bioscience Ag Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
EP2180435A4 (en) * 2007-08-22 2011-01-05 Fujitsu Ltd CONNECTIVE PROPERTY PREDICTIVE DEVICE, PROPERTY PRESENCE METHOD AND PROGRAM FOR CARRYING OUT THE METHOD
JP5844715B2 (ja) * 2012-11-07 2016-01-20 学校法人沖縄科学技術大学院大学学園 データ通信システム、データ解析装置、データ通信方法、および、プログラム
WO2016208776A1 (ja) 2015-06-25 2016-12-29 株式会社国際電気通信基礎技術研究所 多器官連関システムを基盤とした予測装置、及び予測プログラム
JP6559850B1 (ja) * 2018-07-27 2019-08-14 Ｋａｒｙｄｏ ＴｈｅｒａｐｅｕｔｉＸ株式会社 ヒトにおける被験物質の作用を予測するための人工知能モデル

Also Published As

Publication number Publication date
US20230066502A1 (en) 2023-03-02
CN115315754A (zh) 2022-11-08
WO2021145434A1 (ja) 2021-07-22
IL294698A (en) 2022-09-01
JPWO2021145434A1 (https=) 2021-07-22

Similar Documents

Publication Publication Date Title
JP7266899B2 (ja) ヒトにおける被験物質の作用を予測するための人工知能モデル
US20230066502A1 (en) Prediction method for indication of aimed drug or equivalent substance of drug, prediction apparatus, and prediction program
US10553318B2 (en) Individual and cohort pharmacological phenotype prediction platform
KR20230088912A (ko) 인공 지능을 이용해 척수근위축증과 관련된 예측 결과를 생성하기 위한 기법
Dibaeinia et al. Interpretable AI for inference of causal molecular relationships from omics data
WO2024215570A1 (en) Generative machine learning models for omics data and phenotype data
US20140089004A1 (en) Patient cohort laboratory result prediction
US20230253115A1 (en) Methods and systems for predicting in-vivo response to drug therapies
EP4047607A1 (en) Artificial intelligence model for predicting indications for test substances in humans
Trivedi et al. Interpretable deep learning framework for understanding molecular changes in human brains with Alzheimer’s disease: implications for microglia activation and sex differences
Baruah et al. A Review of Recent Advances in Translational Bioinformatics and Systems Biomedicine
Zhang et al. Era of the 4D animal model
HK40068576A (en) Artificial intelligence model for predicting indications for test substances in humans
HK40047964A (en) Artificial intelligence model for predicting effect of test substance on humans
US20250078952A1 (en) Medical Decision Support System using Protein and DNA Language Models
Baruah et al. in Translational Bioinformatics and Systems
Liu Chemical Safety Through the Lens of Omics: Machine Learning Approaches for Pathway Analysis and Predictive Modelling
Xue et al. Bayesian rhythmic model for jointly detecting circadian biomarkers and predicting molecular circadian time in human post-mortem brain transcriptome
Santos et al. CCorGsDB: a database for clock correlated genes in the mouse and human central nervous systems
Xian Use of the Electronic Health Records to facilitate phenotyping, comorbidity analysis, and genomics

Legal Events

Date Code Title Description
P22 Classification modified

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED

Effective date: 20241024

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250612

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250826

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20251027

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251230

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260202